Accelerating TB regimen development: introducing FAST-TB

Accelerating TB regimen development: introducing FAST-TB

Saved in:

Bibliographic Details
Main Authors:	T. Devezin, C. Chisholm, F. Jones, K. Lacourciere, B. Laughon, L. Ramachandra, A. Vernon, L. Zhang, P. Kim, C. Lienhardt
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-11-01
Series:	IJTLD Open
Subjects:	tuberculosis therapeutics drugs drug development
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000011/art00001
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)

Assessment of Haematological Parameters in Drug-Resistant TB
by: Abdulrazzaq Neamah Zghair
Published: (2023-03-01)

2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment
by: M. van den Boom, et al.
Published: (2024-03-01)

The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020
by: A.N. Shapiro, et al.
Published: (2024-06-01)

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
by: A. Vasquez, et al.
Published: (2024-07-01)

Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB
by: E.T. Abbew, et al.
Published: (2024-07-01)

Post-TB sequelae in adolescent pulmonary TB survivors
by: C. Cesilia, et al.
Published: (2025-01-01)

TB drug susceptibility testing in high fluoroquinolone resistance settings
by: F. Saluzzo, et al.
Published: (2024-05-01)

Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan
by: M.A. Khan, et al.
Published: (2024-11-01)

TB survivors: why curing TB is sometimes not enough
by: E. Pontali, et al.
Published: (2024-12-01)

More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
by: G. B. Migliori, et al.
Published: (2024-01-01)

The impact of maximum cross-sectional area of lesion on predicting the early therapeutic response of multidrug-resistant tuberculosis
by: Fuzhen Zhang, et al.
Published: (2025-02-01)

Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan
by: S. Moe, et al.
Published: (2024-09-01)

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

Surgical treatment outcomes and risk factors for post-TB lung disease
by: C. Guo, et al.
Published: (2024-11-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)

Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)

Addressing gaps in the diagnosis of TB in children
by: J. Hoffmann, et al.
Published: (2024-10-01)

Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved]
by: Jay Patel, et al.
Published: (2024-07-01)

Comprehensive care for people affected by TB: addressing TB-associated disabilities
by: M. Calvi, et al.
Published: (2024-05-01)

Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings
by: M. Mbenga, et al.
Published: (2024-04-01)

Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB
by: P. S. Rao, et al.
Published: (2024-02-01)

Yield of TB screening in prisons in Tajikistan
by: S. Moe, et al.
Published: (2024-08-01)

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals
by: B. Muriithi, et al.
Published: (2025-01-01)

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01)

A pilot program to improve TB care with primary and specialty care coordination in TB public health clinic
by: P. Jadhav, et al.
Published: (2024-09-01)

TB prevention activities in the WHO European Region
by: A. Matteelli, et al.
Published: (2024-08-01)

Person-centred language for describing stratified approaches to TB treatment
by: M. Nash, et al.
Published: (2025-01-01)

A two-strain TB model with multiplelatent stages
by: Azizeh Jabbari, et al.
Published: (2016-04-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

Modeling TB and HIV co-infections
by: Lih-Ing W. Roeger, et al.
Published: (2009-08-01)

Type and physical intensity of occupations at pulmonary TB diagnosis
by: M. Saroufim, et al.
Published: (2025-01-01)

Gambaran Tingkat Kepatuhan Pengobatan Pasien TB Paru
by: Endang Martini, et al.
Published: (2024-10-01)

TB among refugees from Ukraine in European countries
by: G. de Vries, et al.
Published: (2024-04-01)

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
by: M.L. Rekart, et al.
Published: (2024-07-01)

Associations between mental illness, TB risk and migrant status
by: S.E. Hayward, et al.
Published: (2024-12-01)

Health-related quality of life in children with presumptive TB
by: M.G. Anthony, et al.
Published: (2024-11-01)

Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa
by: J-D K Lotz, et al.
Published: (2023-11-01)

Disseminated TB associated with acute severe malnutrition in a Roma child
by: P. Kunč, et al.
Published: (2024-12-01)

Analysis of panel physician inquiries to U.S. TB Centers of Excellence, 2018–2022
by: E. Leithead IV, et al.
Published: (2024-11-01)